Emergent Biosolutions logo

Emergent Biosolutions Share Price Today

(NASDAQ: EBS)

Emergent Biosolutions share price is $4.62 & ₹394.85 as on 18 Apr 2025, 2.30 'hrs' IST

$4.62

Market is closed - opens 7 PM, 21 Apr 2025

View live Emergent Biosolutions share price in Dollar and Rupees. Guide to invest in Emergent Biosolutions stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Emergent Biosolutions, along with analyst recommendations, forecasts, and comprehensive financials.

Emergent Biosolutions share price movements

  • Today's Low: $4.50
    Today's High: $4.69

    Day's Volatility :4.04%

  • 52 Weeks Low: $1.82
    52 Weeks High: $15.10

    52 Weeks Volatility :87.92%

Emergent Biosolutions (EBS) Returns

PeriodEmergent Biosolutions IncSector (Health Care)Index (Russel 2000)
3 Months
-54.79%
-2.8%
0.0%
6 Months
-54.62%
-11.0%
0.0%
1 Year
126.47%
-1.9%
0.0%
3 Years
-88.18%
-1.5%
-12.9%

Emergent Biosolutions (EBS) Key Statistics

in dollars & INR

Previous Close
$4.62
Open
$4.64
Today's High
$4.6895
Today's Low
$4.5
Market Capitalization
$251.0M
Today's Volume
$595.8K
52 Week High
$15.1
52 Week Low
$1.8244
Revenue TTM
$1.0B
EBITDA
$53.4M
Earnings Per Share (EPS)
$-3.6
Profit Margin
-18.26%
Quarterly Earnings Growth YOY
0.02%
Return On Equity TTM
-33.67%

How to invest in Emergent Biosolutions Stock (EBS) from India?

It is very easy for Indian residents to invest directly in Emergent Biosolutions from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Emergent Biosolutions stock in both Indian Rupees (INR) and US Dollars (USD). Search for Emergent Biosolutions or EBS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Emergent Biosolutions or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Emergent Biosolutions shares which would translate to 0.185 fractional shares of Emergent Biosolutions as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Emergent Biosolutions, in just a few clicks!

Returns in Emergent Biosolutions (EBS) for Indian investors in Rupees

The Emergent Biosolutions stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Emergent Biosolutions investment value today

Current value as on today

₹2,28,812

Returns

₹1,28,812

(+128.81%)

Returns from Emergent Biosolutions Stock

₹1,26,471 (+126.47%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Emergent Biosolutions (EBS)

-90%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Emergent Biosolutions Stock from India on INDmoney has decreased by -90% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Emergent Biosolutions

  • Vanguard Group Inc

    5.89%

  • American Century Companies Inc

    3.93%

  • State Street Corp

    3.61%

  • BlackRock Inc

    3.54%

  • Amvescap Plc.

    2.83%

  • Millennium Management LLC

    2.73%

Analyst Recommendation on Emergent Biosolutions

Rating
Trend

Sell

    11%Buy

    22%Hold

    66%Sell

Based on 9 Wall street analysts offering stock ratings for Emergent Biosolutions(by analysts ranked 0 to 5 stars)

Analyst Forecast on Emergent Biosolutions Stock (EBS)

What analysts predicted

Upside of 192.21%

Target:

$13.50

Current:

$4.62

Insights on Emergent Biosolutions Stock (Ticker Symbol: EBS)

  • Price Movement

    In the last 3 months, EBS stock has moved down by -53.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 293.8M → 189.3M (in $), with an average decrease of 35.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 114.8M → -31.3M (in $), with an average decrease of 127.3% per quarter

EBS Emergent Biosolutions Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$1.0B
↓ 3.4%
Net Income
$-190.6M
↓ 74.94%
Net Profit Margin
-18.8%
↑ 53.68%

Emergent Biosolutions Technicals Summary

Sell

Neutral

Buy

Emergent Biosolutions is currently in a neutral trading position according to technical analysis indicators.

Emergent Biosolutions (EBS) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Emergent Biosolutions Inc logo
-19.37%
-54.62%
126.47%
-88.18%
-93.42%
Haleon Plc Spon Ads logo
-2.21%
2.4%
24.33%
37.92%
37.92%
United Therapeutics Corporation logo
-9.06%
-23.17%
19.67%
49.68%
60.12%
Zoetis Inc. logo
-10.05%
-21.53%
1.48%
-20.83%
16.7%

About Emergent Biosolutions

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; Botulism Antitoxin Heptavalent for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Trobigard, an atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
Organization
Emergent Biosolutions
Employees
900
CEO
Mr. Joseph C. Papa Jr.
Industry
Health Technology

Management People of Emergent Biosolutions

NameTitle
Mr. Joseph C. Papa Jr.
CEO, President & Director
Mr. Richard S. Lindahl M.B.A.
Executive VP, CFO & Treasurer
Ms. Coleen Glessner
Chief Quality & Compliance Officer
Mr. Paul A. Williams
Senior Vice President of Products Business
Mr. William Hartzel
Senior Vice President of Manufacturing & Bioservices
Ms. Jessica Perl
Senior VP, Corporate Secretary & General Counsel
Ms. Michelle Pepin
Senior VP & Chief Human Resource Officer
Mr. Simon C. Lowry M.D.
Chief Medical Officer and Head of Research & Development

Important FAQs about investing in EBS Stock from India :

What is Emergent Biosolutions share price today?

Emergent Biosolutions share price today stands at $4.62, Open: $4.64 ; Previous Close: $4.62 ; High: $4.69 ; Low: $4.50 ; 52 Week High: $15.10 ; 52 Week Low: $1.82.

The stock opens at $4.64, after a previous close of $4.62. The stock reached a daily high of $4.69 and a low of $4.50, with a 52-week high of $15.10 and a 52-week low of $1.82.

Can Indians buy Emergent Biosolutions shares?

Yes, Indians can invest in the Emergent Biosolutions (EBS) from India.

With INDmoney, you can buy Emergent Biosolutions at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Emergent Biosolutions at zero transaction cost.

How can I buy Emergent Biosolutions shares from India?

It is very easy to buy Emergent Biosolutions from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Emergent Biosolutions (EBS) be purchased?

Yes, you can buy fractional shares of Emergent Biosolutions with INDmoney app.

What are the documents required to start investing in Emergent Biosolutions stocks?

To start investing in Emergent Biosolutions, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Emergent Biosolutions Stock (EBS)?

Today’s highest price of Emergent Biosolutions (EBS) is $4.69.

Today’s lowest price of Emergent Biosolutions (EBS) is $4.50.

What is today's market capitalisation of Emergent Biosolutions?

Today's market capitalisation of Emergent Biosolutions EBS is 251.0M

What is the 52 Week High and Low Range of Emergent Biosolutions Stock (EBS)?

  • 52 Week High

    $15.10

  • 52 Week Low

    $1.82

What are the historical returns of Emergent Biosolutions (EBS)?

  • 1 Month Returns

    -19.37%

  • 3 Months Returns

    -54.62%

  • 1 Year Returns

    126.47%

  • 5 Years Returns

    -93.42%

Who is the Chief Executive Officer (CEO) of Emergent Biosolutions ?

Mr. Joseph C. Papa Jr. is the current Chief Executive Officer (CEO) of Emergent Biosolutions.